Gordon Guyatt's Confession: What the Father of Evidence-Based Medicine Didn't Read (#36)
Gordon Guyatt coined the term 'evidence-based medicine' in 1991 and built the framework doctors worldwide use to evaluate research. His systematic reviews of paediatric gender interventions found only low-quality evidence — yet he signed advocacy statements endorsing these treatments as medically necessary without reading them carefully. In this conversation with Stella O'Malley and her co-hosts, Guyatt admits as much and calls himself 'a dope.' With Irish healthcare policy on paediatric gender services under active review, the episode asks a question with direct local resonance: what happens when the rigour we demand of medicine stops applying to itself?
Gordon Guyatt is not a peripheral figure in medicine. As a professor at McMaster University in Canada, he coined the term 'evidence-based medicine' in 1991 and constructed the intellectual framework that shapes how physicians everywhere — including in Ireland — are trained to evaluate research. His hierarchy of evidence and his User's Guide to the Medical Literature remain foundational texts in medical education worldwide. When a figure of that standing applies his own methods to paediatric gender medicine, the conclusions carry unusual weight. His systematic reviews of youth gender interventions concluded that the evidence is of low quality. Twenty American states cited that work to restrict access to these treatments, prompting Guyatt to respond with fury — calling those restrictions 'egregious' and 'unconscionable.' It is a striking position: the man who produced the evidence is appalled by the policy conclusions others drew from it. That tension between what the evidence shows and how it is interpreted and deployed by different actors — legislators, clinicians, advocates — gives the episode much of its energy. The conversation reaches a pivot point when Stella O'Malley and her co-hosts press Guyatt on a statement he signed endorsing gender medicine as 'medically necessary care for gender diverse youth.' His answer is striking in its candour: he signed without reading the relevant paragraph carefully. 'That was not my paragraph, and I didn't read carefully enough,' he admits. Pushed on it, his verdict on himself is disarmingly plain: 'I was a dope. Okay. I'm sometimes a dope.' From the man who built a career on teaching others to read evidence rigorously, this is a significant admission. The episode also exposes the limits of Guyatt's own expertise in this domain. Asked repeatedly whether adolescents can give meaningful informed consent to interventions affecting their fertility, he deflects, at one point drawing on clinical experience with cognitively impaired elderly patients rather than the specific population in question. When a paediatric endocrinologist is quoted describing discussions of fertility preservation with fourteen-year-olds as 'like talking to a blank wall,' Guyatt dismisses it as a mere anecdote. His own counter-evidence, it emerges, consists of impressions gathered from personal conversations. The standards of rigour he has spent decades demanding of others are, in this particular area, notably absent from his own reasoning. For Irish listeners, this episode arrives at a moment of genuine consequence. Ireland has been closely watching developments in England — the Cass Review, the suspension of puberty blockers, the broader reassessment of paediatric gender services — while navigating its own policy questions about the care offered to gender-distressed young people through the Irish health system. Stella O'Malley, as an Irish psychotherapist who has worked directly with families through these questions, brings a grounded and clinically rooted perspective to the conversation. The interview is a pointed illustration of how advocacy and evidence can become entangled, and why those shaping Irish healthcare policy need to read carefully what they sign.
